Match tier Confirmed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-09

Nawab Ali

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI

Professor

Also affiliated: Creighton University (1992–1996); National Institutes of Health (1995); United States Food and Drug Administration (2009); East China University of Science and Technology (2024); University of Arkansas System (2008–2014); CHI Health Creighton University Medical Center - Bergan Mercy (1992–1995); Yale University (1997–1998); National Institute of Environmental Health Sciences (1995); Shanghai Institute of Technology (2021); Michigan State University (2025); Medical Research Council (1989)

20 h-index 96 pubs 1,677 cited

  • Humans
  • Animals
  • Apoptosis
  • Antineoplastic Agents
  • Cell Survival
  • Inositol Phosphates
  • Photochemotherapy
  • Cell Line, Tumor
  • Nanoparticles
  • Mice
  • Rats
  • Nanomedicine
  • Membrane Proteins
  • Reactive Oxygen Species
  • MCF-7 Cells

Biography and Research Information

OverviewAI-generated summary

Nawab Ali's research program investigates nanomaterial applications in cancer therapy. He is the Principal Investigator on an NSF I-Corps grant of $50,000 focused on "Nano Drug Enabled Cancer Therapy." His work explores the synergistic effects of combining nanomaterials, such as cobalt nanoparticles and carbon nanotubes, with anti-tumor drugs to enhance treatment efficacy.

Ali's publication record includes studies on the cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines, as well as the synthesis of cobalt nanoparticles coated with graphitic shells for localized radio frequency absorption in cancer treatment. He has also published on advanced approaches to breast cancer classification and diagnosis. His research network includes collaborators from the University of Arkansas at Little Rock and the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications.

With an h-index of 20 and over 1,700 citations from more than 100 publications, Ali's work contributes to the fields of materials science and cancer research. His recent activity and ongoing grant support indicate continued engagement in nanomaterial-based therapeutic strategies.

Metrics

  • h-index: 20
  • Publications: 96
  • Citations: 1,677

Positions

  • Professor publications 2003–2026
    University of Arkansas at Little Rock Department of Biology ORCID

Selected Publications

  • Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
    International Journal of Pharmaceutics DOI OpenAlex
  • Dichloroacetic Acid Enhances Photodynamic Therapy-Induced Regulated Cell Death in PANC-1 Pancreatic Cancer Cell Line (2025)
    International Journal of Molecular Sciences 1 citation DOI OpenAlex
  • 95 Targeting Multiple Cancer Hallmarks with Rapamycin-Loaded Gold Nanoparticles—GE11 Peptide Conjugate: A Proteomic Analysis of Pathway Suppression and Cell Death Induction (2025)
    American Journal of Clinical Pathology DOI OpenAlex
  • The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer (2025)
    Cancers 20 citations DOI OpenAlex
  • Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
    ACS Omega 1 citation DOI OpenAlex
  • Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor (2025)
    Journal of Clinical Exercise Physiology 2 citations DOI OpenAlex
  • Serum tissue plasminogen activator after cycling with blood flow restriction (2025)
    Vascular Biology 4 citations DOI OpenAlex
  • IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
    PubMed DOI OpenAlex
  • Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells (2024)
    Bioengineering 4 citations DOI OpenAlex
  • Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
    ACS Applied Bio Materials 6 citations DOI OpenAlex
  • Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
    ACS Applied Nano Materials 9 citations DOI OpenAlex
  • Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy (2023)
    ACS Applied Bio Materials 7 citations DOI OpenAlex
  • Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth (2023)
    Bioengineering 17 citations DOI OpenAlex
  • Correction: Enhancing antibacterial property of aluminum foil by nanostructuring its surface through a steam treatment (2023)
    MRS Advances 1 citation DOI OpenAlex
  • Antibacterial efficacy of surface aluminum oxide nanostructures produced by hot water treatment (2023)
    Nano Express 3 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $50,000 total

NSF PI Apr 2022 - Sep 2022

I-Corps: Nano Drug Enabled Cancer Therapy

I-Corps $50,000

Collaboration Network

175 Collaborators 35 Institutions 4 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics